Millions of injectable nanobots help heal spinal injuries faster

By Matthew Griffin Enhanced Humans and Biotech 6th May 2026

WHY THIS MATTERS IN BRIEF

If it reaches humans, injectable nanorobotics could speed recovery from spinal injuries long considered untreatable.

Matthew Griffin is the World’s #1 Futurist Keynote Speaker and Global Advisor for the G7 and Fortune 500, specialising in exponential disruption across 100 countries. Book a Keynote or Advisory Session — Join 1M+ followers on YouTube and explore his 15-book Codex of the Future series.

Despite significant medical advances, spinal cord damage which often leads to Paralysis remains one of the most difficult physical injuries to treat. Scarring frequently gets in the way of nerve fibre regrowth, while nerve cells usually cannot regenerate on their own. A possible solution? A fleet of stem cell infused, injectable nanorobots that can help nerve cells regenerate. The tiny bots are detailed in a study recently published in the journal .

Japan approves first heart treatment made with reprogrammed human cells

To build their new tools, a team at ETH Zurich in Switzerland engineered microscopic machines that combine living neural progenitor cells (NPCs) – specialised stem cells developed for the spine – with customised nanoparticles. These customised nanoparticles feature two layers – one that is sensitive to magnetic fields and another that translates them into electrical signals.

The Future of Healthcare and Clinical Trials | SCDM, Baltimore | Futurist Matthew Griffin, by Futurist Keynote Speaker Matthew Griffin

Book a Keynote with Matthew

“We place a reservoir in the centre where we trap the cells. Then we inject the nanoparticles and wait for the two components to bind,” , a study co-author and ETH Zurich roboticist, .

Each nanorobot is about six micrometers wide, making them smaller than a red blood cell. However, the number of robots required to pull off a procedure is immense. Millions of nanobots are needed during animal trials. Even with such a high number, the initial experimental results are promising. In tests involving mice with severed spinal cords, nerve cells stimulated by the microrobots began reconnecting at the injury site within 28 days. By the end of the trial, the mice displayed major improvements in movement, gait, coordination, and exploratory behaviour.

New spinal chord treatment lets paralysed man walk again for the first time

Significantly more research is required before these nanobots are ready for primetime, but the team hopes to one day begin testing similar devices in humans. Before that, they need to determine the most effective magnetic fields and how long to apply them to patients. In the meantime, the overall design could also be applied to help treat regenerative issues in organs and wounds.

“The reproducible and scalable production of microrobots using our Lab-on-a-Chip system demonstrates that the platform’s application potential extends beyond basic research,” added Pané i Vidal.

How close is this to treating people?
Still early — the results come from mice, and researchers must first refine the magnetic controls and safety before any human trials of the injectable nanorobots can begin.

ETH Zurich Healthcare Industry Lab on a Chip Microrobots Nanobots Nanoparticles Nanotechnology Paralysis Regenerative Medicine Robots Stem Cells Switzerland

Matthew Griffin / About Author

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.

An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.

As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.

Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.